A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer
This study is ongoing, but not recruiting participants.
Study NCT01181245
Information provided by FibroGen
First Received on May 4, 2009.
Last Updated on May 8, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
